98%
921
2 minutes
20
The objective of the present study was to examine the anti-inflammatory effects of β-sitosterol (SIT), the most common phytosterol in the diet, and to investigate its involvement in NF-κB and STAT1 pathways as potential mechanisms. In addition, the activity of the phosphatase SHP-1 as a negative modulator to these pathways, was investigated. Utilizing murine J774A.1 macrophages, cells were treated with various physiological concentrations of SIT and stimulated with LPS (100 ng/ml) for 6h. Results indicate that 1 and 16 μM SITs increased SHP-1 activity by 300% and 200%, respectively. Similar results were obtained using western blot analysis. Additionally, we observed reductions in the release of some pro-inflammatory cytokines and chemokines as well as an increase in anti-inflammatory IL-10 with SIT treatments. The results also demonstrate the inhibition of STAT1 with SIT treatment. Moreover, translocation of NF-κB to the nucleus was inhibited with SIT as indicated by decreased phosphorylation and the use of ImageStream cytometry. In conclusion, the present study demonstrates the anti-inflammatory effect on macrophages by inactivating STAT1 and NF-κB, which could be mediated by the activation of SHP-1.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.intimp.2011.02.018 | DOI Listing |
Discov Oncol
August 2025
Department of Microbiology, Cholistan University of Veterinary and Animal Sciences, Bahawalpur, Pakistan.
Background: Cancer remains a leading cause of mortality worldwide, characterized by complex genetic and molecular alterations. The Protein Tyrosine Phosphatase Non-Receptor Type 6 (PTPN6), also known as SHP-1, plays a critical role in regulating immune responses and cellular signaling pathways, with emerging evidence suggesting its involvement in cancer progression. Previous studies have linked aberrant PTPN6 expression to tumorigenesis in specific cancers, such as lymphoma and leukemia, where it acts as a tumor suppressor.
View Article and Find Full Text PDFFish Shellfish Immunol
August 2025
Institute of Aquatic Biotechnology, College of Life Sciences, Qingdao University, Qingdao, Shandong, 266071, China; Laboratory for Marine Fisheries Science and Food Production Processes, Qingdao Marine Science and Technology Center, Qingdao, Shandong, 266237, China; Shandong Center of Technology Inn
Src homology region 2 domain-containing phosphatase-1 (SHP-1) is a vital negative regulator of immune cell signaling, yet its role in teleost early adaptive immune response remains poorly understood. Here, we investigated the regulatory role of SHP-1 in early adaptive immune response and the potential underlying mechanisms in Chinese tongue sole (10 ± 2 g and 10 ± 1 cm) infected with Mycobacterium marinum. In this study, SHP-1 expression was artificially manipulated by overexpression and inhibition following bacterial infection, and the former reduced mortality by 33.
View Article and Find Full Text PDFAlthough chimeric antigen receptor (CAR) T cell therapy has revolutionised individualised cancer therapies for relapsed/refractory lymphomas, signalling mechanisms underlying CAR T activation remain incompletely understood, especially among the three generations of CAR T exploiting different signalling domains. Here, using Jurkat T cell as a model, we investigate how costimulation influences tyrosine phosphorylation cascades using LC-MS/MS based phosphotyrosine (pY) proteomics and CD69 expression in the presence of small molecule inhibitors of key TCR signalling regulators. We find that including the ζ-chain in first (ζ-CAR), second (28ζ-CAR and BBζ-CAR), and third (28BBζ-CAR) generation CARs largely determines pY signalling, irrespective of costimulation.
View Article and Find Full Text PDFJ Adv Res
July 2025
Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, PR China; Department of Nephrology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, PR China. Electronic address:
Introduction: Toll-like receptor 4 (TLR4) has emerged as a crucial factor in the pathogenesis of various kidney disease including diabetic kidney disease (DKD), whereas its intricate role in the complex pathophysiology of DKD and associated diabetic podocyte injury remains inadequately elucidated.
Objectives: In this study we aimed to investigate the regulatory role and mechanism of TLR4 dysregulation in diabetic podocyte injury.
Results: Upregulation of TLR4 was demonstrated in high glucose (HG)-challenged podocytes and in streptozocin (STZ)-induced diabetic renal tissue.
Cancers (Basel)
May 2025
Department of Urology, Kaohsiung Chang Gung Memorial Hospital, Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Kaohsiung 83301, Taiwan.
CD300 family members are immunoglobulin superfamily receptors that regulate immune cell function through either activating or inhibitory signals. Among them, CD300a is a prototypical inhibitory receptor, highly expressed in both myeloid and lymphoid lineages, and plays a pivotal role in the pathogenesis of inflammation and tumor immunity. CD300a transduces inhibitory signals in several immune cells-including mast cells, eosinophils, monocytes, dendritic cells (DCs), neutrophils, and natural killer (NK) cells-by recruiting SHP-1 phosphatase to immunoreceptor tyrosine-based inhibitory motifs (ITIMs) and suppressing activation pathways such as Toll-like receptor (TLR)-MyD88 and FcεRI signaling.
View Article and Find Full Text PDF